Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Matthay

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Stem Cell Reports|February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variantsLisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|May 18, 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Nature|August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialJason V Baker, Lianne Siegel, Marcelo Losso, et al.
Annals of Internal Medicine|August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial, Christina Barkauskas, Eleftherios Mylonakis, et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Stem Cell Reports|February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variantsLisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|May 18, 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Nature|August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialJason V Baker, Lianne Siegel, Marcelo Losso, et al.
Annals of Internal Medicine|August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial, Christina Barkauskas, Eleftherios Mylonakis, et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Pageof 5